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Abstract
High-throughput experimental technologies are generating increasingly massive and complex
genomic data sets. The sheer enormity and heterogeneity of these data threaten to make the arising
problems computationally infeasible. Fortunately, powerful algorithmic techniques lead to
software that can answer important biomedical questions in practice. In this Review, we sample
the algorithmic landscape, focusing on state-of-the-art techniques, the understanding of which will
aid the bench biologist in analysing omics data. We spotlight specific examples that have
facilitated and enriched analyses of sequence, transcriptomic and network data sets.
Biological data are exploding, both in size and complexity. High-throughput instruments are
now routinely used in individual laboratories around the world in basic science applications
as well as in efforts to understand and treat human disease. This trend towards the
democratization of genome-scale technologies means that large data sets are being generated
and used by individual bench biologists. Several software platforms and database systems
have been developed for basic data analysis and integration1–3 (BOX 1). However, for
anyone to extract biological insights from these data sets, familiarity with increasingly
sophisticated computational techniques is required. Further complicating matters is that new
genomic data are often best interpreted in the context of the heterogeneous large-scale data
sets that have already been deposited in publicly available repositories. Finally, efficient
means for storing, searching and retrieving data are of foremost concern as they are
necessary for any analysis to proceed. Fortunately, an arsenal of algorithmic ideas —
applicable in a wide variety of biological settings — can be deployed to address these
challenges.
Nowhere is the data deluge more apparent than in the area of high-throughput sequencing. In
the past two decades, improvements in genomic sequencing capability have led to an
exponential growth in the amount of publicly available sequence data that far outstrips the
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growth predicted by Moore’s law4–6. Moore’s law says that computing power and storage
capacity doubles every 18 months, whereas the volume of new sequence data has grown
tenfold every year since 2002 (REFS 7–11). The widening gap between data generation and
computing power implies that many of our established ways of analysing smaller data sets
simply cannot scale, not even with faster computers or with cloud computing or
parallel computing. Further, the increasing diversity of experimental techniques, the
high dimensionality of the resulting data, the noise in high-throughput measurements and the
nature of the underlying biology result in substantial additional challenges in omics data
analyses. The goal of this Review is to highlight a range of fundamental algorithmic ideas
that have been successful in tackling omics data sets and that serve as a launching point for
extracting biological insights from these data. We focus on applications in three diverse but
important areas — sequencing, transcriptomics and networks — as each showcases a
distinct aspect of what we believe are the main computational challenges facing us:
algorithmic efficiency to handle large data sets, sensitive signal extraction from
multidimensional data and contextualization of new data within existing data sets. In this
Review, we primarily focus on algorithms for these three areas, whereas other important
challenges, such as metagenomic12 and proteomic analysis13, will not be covered. Further,
within our areas of focus, it is our hope that a survey of the underlying computational
techniques will be helpful in guiding practitioners in the analysis of their data sets.
We begin with a survey of problems that arise in high-throughput sequencing. We consider
problems that arise at multiple stages in the assembly, mapping, storage and retrieval
pipeline. We show how algorithmic insights involving sophisticated data structures, graph
algorithms and data compression can be deployed to attack some of the computational
bottlenecks in sequencing. Next, we describe sensitive data mining and machine
learning techniques for making sense of transcriptional data sets and look at their
applications to translational biomedicine. Finally, we discuss algorithms for integrating
heterogeneous omics data within the context of biological networks, for which a rich set of
graph-theoretical formulations and algorithms can be leveraged. We close with a brief
discussion of related areas of research that are in need of better computational tools as omics
data accumulate, as well as challenges that remain in developing such tools and
disseminating them to the biological community. Note that links to Web pages and
references for all of the software packages described in this paper are listed in TABLE 1.
Processing, storage and retrieval
Efficient processing, storage and retrieval of large-scale sequencing data sets are crucially
important for modern ‘big-data-driven’ life science. In this section, we describe current
solutions to these problems on the basis of state-of-the-art approaches for indexing large-
scale genomic data (BOX 2; FIG. 1). The key underlying idea of these approaches is that by
smart pre-processing, it is possible to store sequence data in a form that makes subsequent
computations significantly faster.
Genome assembly
Next-generation sequencing technologies, including 454, Illumina, SOLiD and ion
semiconductor, can now yield hundreds of millions of short-read sequences (snippets of
genomic sequences of typically less than several hundred base pairs)14,15 per human
genome. With these evolving technologies, several important computational challenges have
emerged. Among them, genome assembly is one of the most fundamental problems to
address. Before any kind of genomic analysis can commence, it is important to generate a
template sequence (that is, a reference genome) de novo, to which sequences from
individuals and/or species can be compared against and with which variations can be
analysed. Although the quality, depth and coverage of sequencing technologies have vastly
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advanced over the past several years, genome assembly from sequencing data remains a
challenging task16,17. Accurate genome assembly requires sequencing at high depth, and
assembling millions of these short reads into a full-length genome is computationally
difficult as for each read, contiguous sequences need to be identified from a large
unstructured pool of short reads. In addition to fast assembly algorithms, efficient storage
techniques are especially important when carrying out assembly of large genomes, in which
sequencing data can be in the terabytes.
Instead of comparing all possible pairs of sequence segments, most efficient assemblers,
such as EULER18, ARACHNE19,20, Velvet21, SOAPdenovo22, ALLPATHS23 and
ABySS24, have been developed using a graph-based data structure: the de Bruijn graph
(FIG. 1). Assembling reads in a de Bruijn graph reduces fragment assembly to the classical
graph-theoretical Eulerian path problem18,25. In this scenario, the goal of the Eulerian path
problem is to find a trail (that is, a genome sequence or contig) that visits each edge (short
read or sequence fragment) in the (de Bruijn) graph exactly once. There is a linear time
algorithm for finding an Eulerian path in a de Bruijn graph that assembles contigs from
sequence segments or reads. Finally, the assembled contigs are merged into a full-length
genome sequence (see, for example, FIG. 1). Consequently, any such graph-based assembly
algorithm will still take time at least linear in the number of reads and will require a
substantial amount of memory.
Recently, several crucial evaluations of numerous popular genome assemblers, including de
Bruijn-graph-based21–24 and FM-index-based (see BOX 2 and ‘Read mapping in next-
generation sequencing’) assemblers26, have been carried out on four genomes with a wide
phylogenetic range and varying degrees of difficulty27–29. Although these graph-theoretical
methods have substantially advanced genome assembly, they still have great difficulty
accurately assembling large genomes, such as the human genome; different algorithmic
strategies lead to different trade-offs between correctness and contiguity (which is typically
a measure of how much of the genome long contigs span). In large genomes, genomic
repeats often introduce an exponential number of valid Eulerian paths in the assembly
graph30. This complexity poses additional computational challenge for assemblers in
choosing the best paths by using long-range genomic information, such as mate pairs (that
is, two reads from the same clone) and other scaffolding information. Thus, the state of the
art would seem to call for further improvements in sequencing technology, as well as
algorithmic advances in assembly.
Read mapping in next-generation sequencing
Smart algorithms are also required to identify the genomic origin of sequencing reads (that
is, to map reads to a reference genome). The naive string-matching approach, which
compares reads with the whole-genome sequence for each nucleotide, would incur huge
running times owing to the substantial number of reads to be aligned to a genome. To reduce
the high computational cost, one solution is to pre-process the genome into a flexible and
compact data format that allows fast indexing and alignment techniques, such as the FM-
index (BOX 2).
The Burrows–Wheeler Aligner (BWA), Bowtie and SOAP31–35 are arguably the most
widely used short-read alignment software programs. The core technique used by these
programs is the FM-index, which is a compressed data structure for sequence data36 (BOX
2). By constructing a suffix-array-like data structure from a Burrows–Wheeler-
transformed37 reference genome, the FM-index compactly represents its sequence more
efficiently than standard suffix arrays and simultaneously indexes the reference genome for
fast access and mapping (BOX 2). After indexing, the time required for read mapping is
sublinear with respect to the size of the reference genome but at least linear with respect to
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the read data size31–35. The storage space requirement is linear with respect to the size of the
reference genome, but it can be compressed to save space. In addition to read mapping, this
data structure has also been applied for genome assembly26.
Hardware-accelerated algorithms are also used to speed up large-scale, but basic, arithmetic
operations in read mapping. The recently developed Bowtie2 (REF. 31) implements
parallel dynamic programming by fully exploiting the computational power of
modern multicore central processing units (multicore CPUs), thereby
accelerating gapped long-read alignment several-fold. Another read-mapping program,
mrsFast38, uses a cache-oblivious algorithm. Together with efficient indexing data
structures, these sophisticated computer algorithms make various large-scale whole-genome
computational tasks — from read mapping to downstream analyses, such as structural
variation detection and SNP base calling — possible even on personal computers.
Large-scale genome sequence compressed storage and search
As sequencing data rapidly accumulates, one challenge is to reduce the size of this data for
storage and processing. The obvious place to turn is to algorithms that compress these
genomic data sets, and in fact many such compression algorithms exist to reduce the space
required for storage and transmission39–44. Reference-based compression methods39,45 align
read sequences to a reference genome and then store only the differences between the new
sequence and the reference genome. Such methods are ideal for the resequencing of well-
studied genomes, and their compression factor increases almost linearly with the number of
genome sequences. Non-reference-based methods, however, usually rely on string
compression algorithms, which exploit repetitive DNA segments; most of them use well-
known text compression algorithms, such as gzip, BWT and LZ77, in their
implementations40,42,46,47. As an improvement tailored to sequencing data sets, SCALCE47
uses a locally consistent parsing technique that reorganizes the reads such that compression
algorithms can achieve higher compression speed and rates. These string-based approaches
can compress read data sets by factors of 2 to 15.
Compressive storage, however, addresses only a part of the problem, because these
techniques generally require the data to be decompressed before computational analysis. In
addition, any computational analysis, such as sequence search, that runs on the full genomic
library — or even a constant fraction thereof — scales at least linearly in time with respect
to the size of the library, and therefore these analyses effectively grow exponentially slower
every year. Popular search algorithms such as BLAST48 are becoming too slow, and
BLAT49 is soon to follow. To address this crucial problem, the paradigm of ‘compressive
genomics’ was recently introduced45, whereby data are compressed in such a way that they
can be efficiently and accurately searched without decompressing first (FIG. 2).
Compressive genomics exploits the redundancy of genomic sequences to allow
parsimonious storage and fast access45. For example, as human genome sequences differ on
average by only 0.5%50, 200 human genomes contain less than twice the unique data of one
genome, as measured by the number of nucleotides of one full genome plus the nucleotides
differing from it in the rest of the genomes (that is, the nucleotide substitutions, insertions,
deletions and rearrangements that account for the change in each of the remaining genomes).
Thus, although individual genomes are not very compressible, collections of related
genomes are extremely compressible45. Intuitively, given highly similar genomes, any
analysis carried out on one genome accounts for much of the computational work towards
the same analysis on the others. These compressed large genomic data sets can be analysed
with new algorithms that operate solely on the compressed non-redundant data without
decompressing it. FIGURE 2 presents the CaBLAST and CaBLAT compressive genomics
algorithms for BLAST and BLAT that have a similar accuracy to BLAST and BLAT yet
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have runtimes that scale sublinear to the total size of genomic data and almost linear to that
of the non-redundant data.
High-throughput sequencers also provide a powerful approach for transcriptome
quantification by RNA sequencing (RNA-seq)51–53. By sequencing the whole transcriptome,
researchers are able to identify transcripts and to estimate gene expression levels. As with
short-read DNA sequence analysis, short reads are either mapped to reference genomes and
transcriptomes54 or assembled de novo55, before transcript counting and data normalization.
The unique characteristics of RNA-seq data present substantial algorithmic challenges in
their analysis. For instance, the existence of novel gene fusions and alternative splicing
make mapping and assembly of RNA-seq data extremely difficult owing to ambiguity in
read mapping54,55. Bioinformatic analysis of RNA-seq data sets is still in its infancy; in
addition to quantification of expression levels, substantial work remains to be done on
interpreting these data56.
Data mining for transcriptomics
RNA-seq51,52 and microarray57 experiments have produced large repositories of high-
dimensional transcriptomic data58. Challenges include identifying cell-specific expression
signals within tissue profiles, identifying regulatory and phenotypic genes and modules, and
integrating multiple expression data sets for disease-related analysis. In this article, we focus
on some of the most recent algorithmic developments in data modelling to decipher and to
integrate multiple experiments over transcriptomic data sets. Also relevant are excellent
review articles on more traditional expression analysis59,60, data normalization61 and RNA-
seq data analysis62,56 (for example, integrated pipelines such as Tophat, Cufflinks and
Cuffdiff54,63–65).
Identifying cell-specific expression signals
Heterogeneity of cell types may confound gene expression analysis. Transcriptomic
expression methods, such as microarray techniques, require a large quantity of mRNA to
obtain reliable expression levels. As a result, the tissue samples used for mRNA preparation
often consist of several different cell types. Thus, expression levels based on tissue samples
with varying cell type compositions are difficult to compare with or to interpret66,67. This
issue is particularly problematic when carrying out differential analysis between complex
disease and normal samples in clinical studies.
Similarly to deconvolution methods that are used in digital signal processing, and that were
first used in electrical engineering, researchers have developed approaches to identify
expression signals for each cell type from an expression study. Linear algebraic methods62
have proved to be effective for this task. These methods require measured cell type
proportions. These proportions of cell types are used to weight a linear mixed model,
which is a statistical model that is fit on the basis of the assumption that the overall observed
expression signal can be constructed from a linearly weighted sum of the expression levels
from each cell type (weighted according to the proportion of cells in the sample). After the
model is fit, the expression profiles for each cell type are identified from overall expression
signals. A similar method has also been designed to estimate the tissue components from
surgical samples68. When the mixed cell type proportions are not available, methods based
on matrix factorization69 or differential geometry70 have been developed to
estimate simultaneously both mixture proportions and expression profiles for each
component cell type.
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Identifying regulatory genes and modules
Perhaps the most fundamental type of analysis is to detect the differential expression of gene
sets in conditions of interest to infer key genes and pathways (for example, by identifying
regulatory genes and linked pathways or to implicate genes or pathways in a disease-based
analysis). To accomplish these tasks, numerous statistical methods, such as gene set
enrichment analysis (GSEA)71, GenePattern72, joint clustering73,74 and DEseq75, have been
devised and widely applied to analyse differentially expressed genes and gene sets56,57. A
gene module consists of a group of genes that jointly carry out specific biological functions.
Module discovery seeks to identify differentially expressed genes or dysregulated pathways
in disease states, along with the regulatory relationships between them. To mine pathways
and/or modules from transcriptome data sets, researchers have developed a number of
mathematical models76–88. Among the most popular are probabilistic graphical models,
which describe a distribution that can explain the observed transcriptome data. The nodes in
the graph represent the genes (or modules), and the edges define the relationship between
two genes (or modules). Graphical models can thus describe and uncover putative
interactions between genes or modules and have been applied to these types of problems
arising in gene expression analysis.
An important question is what the regulatory relationships or co-expression patterns are
among genes. Over the past decade, graphical models have been extensively applied to this
problem. IDA (for ‘interventional calculus when directed acyclic graph is absent’)89 and
nested effects models90 are two recently developed graphical models that construct putative
regulatory relationships between genes from transcriptomic data. Sparse learning is another
recently introduced mathematical concept used to mine gene or module regulatory patterns.
The key idea is that the gene regulatory network is sparsely structured; that is, the
expression of any gene is directly regulated by only a few other genes, and this allows a
concise representation of genes that explain the differential phenomena in gene expression.
SPARCLE (for ‘sparse recovery of linear combinations of expression’) is a machine
learning method that finds a gene set of minimum size such that its expression profile
linearly fits the given genes of interest91. For example, genes that regulate specific pathways
would correlate linearly with their targets. This idea is thus formulated as a compressed
sensing problem and is solved through linear programming. This method is purely
unsupervised (that is, no training data are required). In contrast to principle component
analysis (PCA)92,93 or correlation-based methods93,94, SPARCLE is able to find robust
gene sets of much smaller size from high-dimensional transcriptomes (that is, transcriptomes
in which a large number of gene expression changes are observed), such that they can
provide potential biological context for the given genes of interest. Experimental results also
indicate that SPARCLE outperforms correlation-based approaches in predicting protein–
protein interactions and genetic associations91. The sparse factor analysis method PEER95,96
has been developed to infer a small set of ‘hidden cellular phenotypes’ or expression
patterns in the gene expression data that can explain the highest variability in gene
expression across multiple samples. Similarly to SPARCLE, PEER enforces a sparsity
constraint on the size of the hidden cellular phenotypes. By incorporating biological prior
knowledge, the derived cellular phenotypes can be used to infer pathways or transcription
factors.
Identifying gene expression alterations in disease
With the recent accumulation of cancer genomic data sets, another important problem is to
identify genes and modules in two-way comparisons between tumour cells and normal
cells76,88,97,98. For example, CONEXIC compares gene expression data in cancer tissue and
normal tissue by extending the causal graphical model76, which connects gene sets with
edges to represent their interactions, to elucidate dysregulated gene modules from cancer
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genomic data88. By leveraging gene expression data and the corresponding copy number
variants (CNVs), CONEXIC builds such module networks to distinguish between the
CNV-affected genes, which are believed to be main drivers of cancer, and abnormally
regulated genes, which are affected by the dysregulation of gene expression and are difficult
to identify.
Two other popular pieces of software, PARADIGM and PARADIGM-SHIFT, implement a
Bayesian network to construct pathways from cancer transcriptomic profiling data
sets97,98. By taking pathways into account, PARADIGM can identify weak but clinically
relevant signals, which are often overlooked when only single genes are considered.
PARADIGM-SHIFT has been extensively applied in recent cancer genomic research
studies, including The Cancer Genome Atlas (TCGA)99–101. In the future, these ideas may
find use in multiclass (that is, beyond simply case versus control studies) and cross-study
analyses as well.
The lack of standardized nomenclature and annotation methods has made large-scale, multi-
phenotype analyses of multiple tissues and disease states difficult. Large-scale gene
expression investigations have had preliminary success at elucidating phenotypic gene
expression signals102–104 and applying those signals to downstream analyses, such as drug
repurposing104,105. However, such approaches still directly measure transcriptional
differences between two phenotypes, inherently imposing subjective decisions about what
constitutes an appropriate control population. This presupposition can limit the scope of
such analyses to differentiate between biological processes that are unique to a particular
phenotype or part of a larger process that is common to multiple phenotypes (for example, a
generic ‘cancer pathway’). To address this limitation, one recently developed approach is
Concordia106. Here, a ranked list of marker genes for a given complex phenotype is
generated by querying a gene expression database sorted by gene expression intensity for
each phenotype106,107. Concordia is able to classify tissue types with a high degree of
accuracy, such as metastasized tumour samples, which strikingly resemble their tissue of
origin106. Similar methods have also been developed with linear algebraic techniques to
analyse existing disease signatures108 and to identify gene modules across multiple gene
expression data sets109.
Integrative interactomics
Transcriptomic and other complex functional genomics data sets that are arising from high-
throughput experimental biology benefit from analysis in the context of known cellular
networks, which provide a holistic framework for interpretation. Although far from
complete, large-scale networks have been determined for numerous organisms, including
humans and other model organisms110–114. These networks, or interactomes, are commonly
represented as graphs, in which nodes correspond to biological components (for example,
genes, RNAs, proteins or metabolites), and edges correspond to known interactions among
them (for example, physical, regulatory or genetic). Integrative interactomics analyses are
typically premised on modularity, which is a key organizational property of cellular
networks in which molecules that work together to carry out a specific biological process are
enriched in interactions among themselves115.
Analysis of heterogeneous genomic data sets
Protein–protein and regulatory interaction networks provide a physical ‘scaffold’ with which
to uncover modules that are specific to conditions of interest. Early pioneering work, now
implemented as the jActive modules plugin for Cytoscape3, introduced the concept of active
subnetworks, which consist of connected regions in physical interaction networks that
manifest significant expression changes in specific contexts116. Numerous variations of this
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idea have since been introduced. For example, JACS allows for an arbitrary measure of
similarity (for example, including, but not limited to, co-expression) between pairs of genes
with the goal of uncovering connected subnetworks that exhibit high similarity117. Further,
local clustering approaches, such as SPICi, that rapidly uncover densely interconnected sets
of proteins corresponding to functional modules allow enumeration of context-specific
modules when interactions are weighted by co-expression values that change depending on
the condition of interest118. Better methods to determine the differences between modules
uncovered across multiple conditions, and to reason about them, represent an important
avenue for future work.
Network flow — a classic formulation in graph algorithms in which each edge has a
capacity to carry flow that is pumped into the system from source nodes — has proved to be
a powerful and general concept in integrative interactomics (FIG. 3b). An early application
used flow to propagate biological process annotations over a protein–protein interaction
network119. Flow can also be used to identify proteins that respond to a particular
perturbation in high-throughput screens that are either noisy or incomplete and will therefore
miss proteins of interest. For example, high-scoring hits from an RNA interference (RNAi)-
based knockdown study in flies were mapped to the protein–protein interaction network, and
to uncover the affected pathways the Influence Flow algorithm computed the simplest
explanation of a signalling pathway perturbation that was consistent with both the network
and RNAi data by constructing a set of constraints for which the solutions correspond to
high-confidence estimates of the structure of the pathway120. Flow-based optimization is
also used in ResponseNet to reconstruct pathways from protein–protein and protein–DNA
interaction networks121,122. A minimum-cost flow approach connects the genetic interactors
of a given gene with genes that have expression changes when this gene is knocked out. The
prize-collecting Steiner tree problem provides an alternative theoretical formulation to
the problem of interconnecting a seed set of proteins. In this case, each initial hit is
associated with a prize, and each interaction is associated with a cost. The goal, as
implemented in SteinerNet, is to identify a subset of the identified hits that are connected
directly or through intermediate proteins in protein–protein and transcriptional regulatory
networks, such that the sum of the cost of the chosen interactions and the prize of the hits
not included is minimized123,124.
Cellular networks also serve as a platform from which to infer causation in signalling and
regulatory pathways. Probabilistic models have integrated network and expression data from
gene knockout expression studies to predict cell-signalling cascades125. Random-walk-
based approaches (FIG. 3c) have inferred causal genes driving expression variation within
mapped expression quantitative trait loci (QTLs) by uncovering those genes that are visited
more frequently in random walks initiated at target genes126. The flow of information from a
locus to target genes has also been determined using electric current flow approaches127,128,
in which each edge is associated with a conductance, and genes for which the nodes have the
highest current through them are predicted to be causal; electric networks have previously
been shown to be tightly linked to random walks on graphs129. By integrating protein
annotations into network analysis, potential signal and regulatory pathways can be modelled
as complex network schemas or patterns — with descriptions of proteins along with desired
topologies and interactions among them — and matches rapidly uncovered in interactomes
using NetGrep and other related tools130–133.
Comparative interactomics approaches are a powerful alternative approach for discovering
modules and pathways across cellular networks. The central idea is that if a module is
known in one organism, searching for homologues of its component proteins, along with
conserved patterns of interactions, can yield information in other organisms134–139. The
Isorank algorithm is one such network alignment approach; it combines sequence similarity
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and network similarity constraints to construct and to solve an eigenvalue problem. It
has been used to align and to analyse networks based on protein–protein interaction134,135,
genetic interaction140 and metabolic data141.
Interactome analysis of disease data sets
Some of the largest growing genomics data sets are arising in the context of human disease.
These include genetic perturbations, such as mutations or copy number variations, observed
in whole-genome or exome sequencing of afflicted individuals (for example, as observed in
cancers) and variants identified as associated with disease through genome-wide association
studies (GWASs), along with other high-throughput functional data (such as gene
expression and DNA methylation data). The multifactorial nature of complex diseases
suggests that although the genes underlying these diseases may differ among afflicted
individuals, the pathways that are perturbed are likely to be shared, and thus proteins
associated with the same disease have a tendency to interact142. Further, genes in loci
identified by GWAS as being associated with complex diseases have been found to be
‘close’ within interaction networks135,143. Thus, network modularity can be leveraged to
carry out disease gene prioritization and to uncover pathways associated with disease
through a diverse set of methods144, including network flow145 and random walks146,147. In
the context of analysing cancer genomes, approaches based on diffusion148 and shortest
paths149 (Hotnet and Netbox) have been applied to identify subnetworks enriched in
recurrently mutated proteins across patients. These network approaches complement
approaches for disease gene prioritization based on assessing the impact of mutations on
protein function150–152.
Permutation-based approaches, such as DAPPLE, are a useful means for testing the
modularity of genes that are putatively associated with a specific disease143. Here, candidate
disease genes are evaluated for proximity with respect to each other in the network. To
assess significance, these values are compared with those computed on randomized
networks that are obtained by shuffling protein names in an interaction-degree-preserving
manner. Further, we note that network approaches may provide a powerful paradigm to
recover potentially interesting associations in GWASs and other high-throughput
experiments that are individually of marginal significance but are found in subnetworks
enriched with other such genes and thus in aggregate suggest biological importance.
The molecular mechanisms that underlie disease can vary among affected individuals, and
this can be evident at the mutational level or reflected in cellular measurements.
Formulations based on extensions of the classic algorithmic problem of set cover have
proved to be useful in considering this heterogeneity128,153,154. For example, in DEGAS, a
set of dysregulated or mutated genes is determined for each individual, and the goal is to
find a subnetwork in which each individual is ‘covered’ by some number of genes in the
subnetwork, where a gene covers a disease individual if the gene is either dysregulated or
mutated in that disease155. Such an approach naturally models both the modularity and the
heterogeneity in disease. Nevertheless, consideration of patient heterogeneity represents a
major challenge in further research in disease interactomics. A more complete discussion of
the power of network biology approaches for understanding disease and disease
heterogeneity can be found elsewhere156.
Conclusion and future prospects
It is clear that we are moving into an era in which diverse high-throughput data — genomes,
transcriptomes, proteomes, interactomes and methylomes, among others — are routinely
generated in individual laboratories. Understanding the algorithms underlying omics
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analyses will result in their correct application in answering biological questions. Here we
outline some areas where further algorithms are needed to aid the bench biologist.
The recently developed compressive genomics approach45 represents an important
milestone for designing compressive algorithmic frameworks that are adaptable to large-
scale genomic data. Introducing compressive techniques for next-generation sequencing
read data sets and their quality scores remains a major challenge. Such techniques would
allow, for example, the type of meta-analyses across data sets that are routinely carried out
using existing gene, protein and genome databases.
As transcriptomic data shifts from microarray to next-generation sequencing, we will also
need to develop transcriptomic analysis methods to handle this new form of data. The
experimental advantages of RNA-seq157 over microarrays — including, for example, the
detection of transcript structure and alternative isoforms — add substantial complexity to
these analyses. Further, high-throughput sequencing provides ‘read-out’ for a range of
functional genomics experiments (for example, chromatin immunoprecipitation followed by
high-throughput sequencing (ChIP–seq)158 to detect protein–DNA interactions, ultraviolet
crosslinking and immunoprecipitation followed by sequencing (CLIP–seq) and related
techniques159–162 to detect protein–RNA interactions and ribosome profiling163 to
determine protein translation), and the tremendous amounts of data produced from these
experiments, along with their specific attributes, will be a challenge to existing analysis
paradigms.
As high-throughput technologies continue to improve, omics measurements will be made
across organisms, individuals, cell types and conditions and eventually at the level of
individual cells. Much future work in integrative interactomics will focus on characterizing
the differences that distinguish individuals and cells from each other. These differences may
reflect natural variation, differential functioning, disease pathology and other types of
heterogeneity. Comprehensive, multimodal omics approaches are likely to be especially
fruitful in uncovering the molecular landscapes underlying observed phenotypic variations.
Although several software platforms have been developed for basic data analysis and
integration1–3, we close by highlighting the growing need for ‘translational’ computational
biology. As new sophisticated algorithms continue to enter the toolbox of the most
computationally expert biologists, wide adoption in the broader community will depend on
user-friendly software tools and websites, with extensive documentation and easy-to-follow
tutorials. Thus, although this Review has focused on the central role of algorithm
development in high-throughput biology, it is clearly also essential to package effective
methods into widely available software that can be easily and correctly used by scientists
from a broad range of backgrounds.
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Glossary
Cloud computing The use of computing resources distributed in the Internet to store,
manage and analyse data, rather than doing so on a local server or
personal computer.
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Parallel
computing
A form of computation that allows numerous calculations to be
carried out simultaneously, thereby accelerating computation. On the
basis of this principle, many large-scale computational tasks can then
be divided into smaller ones and solved on multiple machines
concurrently.
Machine
learning
techniques
Empirical data are taken as input, the relationship among the data is
mathematically or statistically modelled, and patterns or predictions
are generated. Supervised learning algorithms infer a function from
labelled data features and predict labels on future input; unsupervised
learning algorithms model the patterns or the distribution of a given
unlabelled data set.
Parallel dynamic
programming
A technique that splits a large dynamic programming problem,
usually by filling a table that can avoid redundant calculation, into a
number of subproblems and computes all subproblems in parallel
using multiple central processing units (CPUs). The computing
speed-up scales almost linearly with the number of CPUs.
Multicore
computer
processing units
(Multicore CPUs). Single computing processors with two or more
independent computing units (called cores). Running multiple
instructions on multiple cores at the same time can increase the
overall speed of programs.
Cache-oblivious
algorithm
Takes advantage of the cache system of the central processing unit
(that is, the local memory of frequently accessed data) to avoid
expensive memory access operations and thus to improve efficiency;
the intrinsic design of these algorithms does not require computer
programs to be tuned for machines with different cache systems.
Linear mixed
model
A statistical model that models the observed effects from multiple
different hidden factors; the effects are additively mixed according to
the proportions of their corresponding factors.
Matrix
factorization
A method for decomposing a matrix into the product of two matrices.
It can be applied to identify individual factors involved in a mixed
observation.
Differential
geometry
A mathematical discipline for studying geometric objects, such as
curves and surfaces, using the techniques of differential and integral
calculus.
Linear
programming
A mathematical program for the optimization of a linear objective
function, subject to linear constraints. Such functions capture the
linear relationship between variables for the problem being
optimized.
Principle
component
analysis
A tool for transforming a set of observations with correlated
variables into a set of linearly independent variables called principle
components, making sure that the first principle component accounts
for the largest variability of the data.
Copy number
variant
(CNV). Corresponds to abnormal number of copies of one or more
segments in the genome. CNVs can be caused by structural
rearrangements of the genome such as deletions, duplications,
inversions and translocations.
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Bayesian
network
A statistical model that describes the distribution of a set of random
variables by a directed acyclic graph that represents the relationship
among the random variables. For example, in a Bayesian network for
a regulatory relationship for a set of genes, each variable represents a
gene and each directed edge denotes either activating or repressing
regulation between two genes.
Steiner tree
problem
Formulated on a network to find a minimum-length subnetwork that
interconnects a set of seed nodes. Any two seed nodes may be
connected by an edge or a path through other nodes.
Random walk A mathematical formulation of a number of successive random steps
on a graph. It has been widely used to explain stochastic
observations, such as diffusion in biological networks.
Eigenvalue
problem
The aim of this is to find a non-zero vector (that is, eigenvector),
given a square matrix, such that the multiplication of the two is only
different by a scalar factor.
Set cover Given a set of elements and subsets, the goal is to find the minimum
number of subsets that cover all the elements.
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Box 1 | Platforms for biological data analysis
Software platforms for biological data analysis
A long-standing challenge for practitioners is the proper use of software, including, for
example, choosing suitable algorithms, installing software, setting correct parameters and
assembling multiple programs into an integrative pipeline. These issues have become
even more serious in the omics era, when high-throughput experiments have facilitated
numerous large-scale analyses, thus requiring increasingly sophisticated computational
tools. To address this need, multiple integrative software platforms have been developed
with user-friendly interfaces. Some of these tools, such as Galaxy and Bioconductor, also
aim to increase the ease of reproducibility of analyses. Computational scientists can then
easily distribute their programs through such platforms. Some representative platforms
are listed in the table.
Biological database systems
Similarly to the accessibility of computational tools, coordination of omics data sets can
be difficult. Data sets are usually generated by different laboratories and can have
different dimensionalities and organization. There have been substantial efforts towards
formatting, storing and calibrating data sets, from the early Protein Data Bank, the US
National Center for Biotechnology Information (NCBI) sequence data sets and the
University of California, Santa Cruz (UCSC) Genome Browser164, to very recent
consortia, such as the well-known ENCODE165 and modENCODE166 projects. To allow
better sharing of data, several biological database systems have been developed to
provide easy access to heterogeneous data sets for biologists. Many of these systems have
also been integrated with software platforms, such as the ones mentioned above, so that
researchers can build workflows for their analyses without writing extra code to integrate
multiple programs.
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Name Main function Open source? URL
Software platforms
Bioconductor General purpose Yes http://www.bioconductor.org
Taverna General purpose Yes http://www.taverna.org.uk
Galaxy Sequence analysis Yes http://www.galaxyproject.org
GenePattern General purpose Yes http://www.broadinstitute.org/cancer/software/genepattern
Cytoscape Network analysis Yes http://www.cytoscape.org
BioDAS Structural biology Yes http://www.biodas.org
Database systems
BioMart General database Yes http://www.biomart.org
Addama Heterogeneous database Yes http://www.systemsbiology.org/addama
SDCubes Heterogeneous database Yes http://www.semanticbiology.com/software/sdcube
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Box 2 | Indexing techniques for sequencing data
Burrows–Wheeler transformation (BWT) is a string transformation that converts highly
redundant sequences (for example, the human genome) into a format that can easily be
compressed (see below). It is carried out by: generating all rotations of the input such that
each position becomes the starting position exactly once; sorting the rotated sequences in
alphabetical order; and extracting the last column of all sorted rotations as the output
sequence. If there are substrings that occur multiple times in the full sequence, then the
transformation will cluster these substrings together, resulting in single-character
repetitions in the final column; hence, the repetitive structure of the output sequence
facilitates compression. Furthermore, BWT allows an efficient inverse transformation
that can fully recover the original sequence from the transformed output. These features
thus enable BWT to be a useful pre-processor for lossless data compression, such as
bzip2 and Huffman encoding.
As opposed to rotations used in BWT, a suffix array is a sorted array that indexes all
possible suffixes of a sequence (see below). The array is constructed by sorting all of the
suffixes alphabetically. The order of each entry in the suffix array represents the ranking
of that suffix in the sequence. By taking the similarity among suffixes, the suffix array
can be constructed quite efficiently in practice. After a suffix array has been built, queries
can be carried out by many different algorithms. For instance, binary search compares the
query string and the middle element of the array and repeats the search on the left or right
subarray according to the comparison; this requires only time O(m log(n)), where m is the
length of the query, and n is the length of the original sequence167. As read length is
typically very small (m < 100), and as the reference genome length n is substantial, the
query time for the suffix array is significantly faster than naive sequence matching, which
requires O(m n) time. Although further algorithmic advances have increased the speed of
suffix array queries to O(m) time, the memory required for a suffix array for the whole
human genome is very expensive; all suffixes need to be stored, and thus the size of the
suffix array would be much larger than the size of the genome.
Advantageously, the FM-index is a hybrid of BWT and suffix arrays. The FM-index
contains the information from all suffixes of the original sequence and allows fast
subsequence mapping and counting in O(m) time36. See the original text in REF. 36 for
technical details and illustrations on construction and query operations36 (also see Figure
1 of REF. 30). Compared with the space requirement of suffix arrays, only O(n) space is
needed for the FM-index on a genome of length n36. These features make the FM-index
ideal for short-read mapping, where the read length m is usually quite small, and the size
of the reference genome is large. In addition to read mapping, this data structure has been
applied for genome assembly26.
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Figure 1. De Bruijn graph of DNA sequence assembly
Each directed edge in a de Bruijn graph denotes a sequence read or a fragment of fixed
length (4 bp in the figure); the source node of this edge is a prefix string of the read omitting
the last nucleotide; the destination node of this edge is a suffix string of the same read (or
sequence fragment) by omitting the first nucleotide. In the example shown in this figure, the
top panel is a pool of representative short reads or fragments. In the middle panel, each node
denotes a unique sequence prefix or suffix segment of length 3 bp found in the original reads
of length 4 bp. The assembly of DNA sequences (segments) is thus represented as a de
Bruijn graph. Assembling reads (or sequence fragments) in a de Bruijn graph reduces the
problem to a fragment assembly problem that can be formulated as the goal to find a trail or
Eularian path that visits each edge (read or fragment) in the (de Bruijn) graph exactly once.
Nucleotides with a red background occur more than once in the sequence. Numbers on the
edges represent an ordered Eulerian path through the de Bruijn graph, which can be
followed to reconstruct the assembled sequence from the compact graph representation.
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Figure 2. Application to sequence search
a | Flow chart of CaBLAST. First, redundancy in the genomic database is identified and
removed to create a unique database consisting of a smaller set of segmental exemplars.
Only the first occurrence of repetitive sequence segments is retained, as represented by the
blue background, and other similar regions are removed (blanked out in the pre-processing
step) and encoded in a links table to their original locations. The red background indicates
locations of unique bases within the repetitive element. An edit script compression
technique45 is used to encode similar sequence fragments with reduced storage in a
compressed database. After the compressed database is constructed, a coarse-to-fine strategy
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is adopted for sequence search. First, a BLAST search is run using the query sequence
(shown with a pink background) against the unique database with a relaxed E value
threshold to identify high-scoring hits. Second, the additional candidate hits are recovered
by tracing through the links table. Third, BLAST is run against the final candidate hits. b,c |
CaBLAST storage requirements and running time comparisons on uncompressed (black)
and compressed (blue, full compressed database; red, only unique database or coarse search)
genome sequence databases consisting of 1 to 36 yeast genomes45.
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Figure 3. Integrative interactomics applications
a | Schematics of computational formulations that arise when incorporating genomic data
within a network context. Nodes correspond to biological components (for example, genes,
proteins or other molecules), and edges correspond to known interactions among them (for
example, physical, regulatory or genetic). In the left-hand panel, an attribute of interest has
been measured for all molecules of the network (for example, differential gene expression
values, shown in shades of blue and red). The goal is to uncover subnetworks that contain
genes with similar values of attributes (for example, similarly differentially expressed, as
shaded in similar colours in this panel). In the middle panel, a subset of genes has been
identified as being of interest (for example, involved in some disease, shown in blue), and
the goal is to uncover additional genes that take part in the same underlying pathway or
functional module, as suggested by proximity in the network. In the right-hand panel, two
subsets of genes, shown here in blue and red, have been identified (for example,
corresponding to target genes, the expression values of which have changed and genes
within loci that are associated with these targets), and the goal is to find paths in the network
connecting these genes. b | Given an initial set of molecules (for example, genes that affect a
phenotype of interest or that are involved in some disease), subnetworks containing
additional genes of interest can be inferred using network flow approaches. The initial set of
molecules comprises source nodes, from which fluid is pumped into the network, as
represented by the taps. Each interaction between nodes can be weighted (for example,
according to an estimate of the reliability of an interaction), and this weight can be used as a
capacity to restrict the amount of flow that can go over the edge, as shown by the width of
the edge. At each iteration of the algorithm, a node pumps flow to its neighbours while
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satisfying capacity constraints, and flow spreads through the network from the source nodes.
Higher amounts of fluids through a node are shown with darker colours (right). In the classic
network flow formulation, the amount of fluid in the network is maintained, whereas in
other formulations fluid is pumped into the source nodes at a constant rate117,160. c |
Random-walk-based approaches are also used to identify subnetworks from an initial set of
molecules of interest. Starting from an initial node (for example, one of a set of known
disease genes), a neighbour is repeatedly selected at random according to the distribution of
transition probabilities between nodes, which can be set uniformly or based on estimates of
the reliabilities of interactions or some other attribute of interest, such as co-expression
between genes. In most applications, the walker also has some probability of staying at its
current position at each step or jumping to any node chosen according to a pre-specified
probability distribution (for example, to each disease gene with equal probability). In the
shown example, at each time point, the distribution of the walker’s position is shown in
blue. In the fourth time step (right), the walker is equally likely to be in one of two locations,
and at each subsequent step, the probability of the walker being at each location can be
estimated. After the probability estimates have converged, proteins are ranked (for example,
as candidate disease genes) according to the probability that the walker is at the
corresponding node.
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Name Main function Open source? URL
Software platforms
Bioconductor General purpose Yes http://www.bioconductor.org
Taverna General purpose Yes http://www.taverna.org.uk
Galaxy Sequence analysis Yes http://www.galaxyproject.org
GenePattern General purpose Yes http://www.broadinstitute.org/cancer/software/genepattern
Cytoscape Network analysis Yes http://www.cytoscape.org
BioDAS Structural biology Yes http://www.biodas.org
Database systems
BioMart General database Yes http://www.biomart.org
Addama Heterogeneous database Yes http://www.systemsbiology.org/addama
SDCubes Heterogeneous database Yes http://www.semanticbiology.com/software/sdcube
Nat Rev Genet. Author manuscript; available in PMC 2014 March 26.
